Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ETAMI-Study: Early Thienopyridine Treatment to Improve Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

NCT01327534 is registered in ClinicalTrials.gov with Stiftung Institut fuer Herzinfarktforschung as lead sponsor.

NCT NCT01327534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ETAMI-Study: Early Thienopyridine Treatment to Improve Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
Lead sponsor
Stiftung Institut fuer Herzinfarktforschung
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2011
Completion date
July 31, 2013
Enrollment
63 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction, stemi